Successful re-challenge with darbepoetin in a patient with rHu-EPO-induced pure red cell aplasia refractory to immunosuppressive drugs

Nephrol Dial Transplant. 2008 Jul;23(7):2416-8. doi: 10.1093/ndt/gfn051. Epub 2008 Apr 3.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Darbepoetin alfa
  • Drug Resistance
  • Erythropoietin / adverse effects*
  • Erythropoietin / analogs & derivatives*
  • Erythropoietin / immunology
  • Erythropoietin / therapeutic use
  • Hematinics / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Recombinant Proteins
  • Red-Cell Aplasia, Pure / chemically induced*
  • Red-Cell Aplasia, Pure / drug therapy*
  • Red-Cell Aplasia, Pure / immunology
  • Treatment Outcome

Substances

  • Hematinics
  • Immunosuppressive Agents
  • Recombinant Proteins
  • Erythropoietin
  • Darbepoetin alfa